We are live on
!
Find out more
Ocular Therapeutix
OCUL
OCUL
269 hedge funds and large institutions have $1.77B invested in Ocular Therapeutix in 2026 Q1 according to their latest regulatory filings, with 77 funds opening new positions, 104 increasing their positions, 59 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
76% more repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 59
51% more first-time investments, than exits
New positions opened: 77 | Existing positions closed: 51
8% more funds holding
Funds holding: 249 → 269 (+20)
5.05% more ownership
Funds ownership: 89.93% → 94.97% (+5%)
4% more call options, than puts
Call options by funds: $22.1M | Put options by funds: $21.2M
24% less capital invested
Capital invested by funds: $2.33B → $1.77B (-$560M)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
269
Holders Change
+20
Holders Change %
+8.03%
% of All Funds
3.31%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.06%
New
77
Increased
104
Reduced
59
Closed
51
Calls
$22.1M
Puts
$21.2M
Net Calls
+$860K
Net Calls Change
-$25.9M
Top Buyers
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$111M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$54.6M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$43.1M |
| 4 |
VA
VR Adviser
New York
|
+$28.9M |
| 5 |
CC
Commodore Capital
New York
|
+$24.5M |
